|
|
 |
|
Viewing report
|
|
 |
 |
2001 Results: Financial Results of the Top 16 Pharmaceutical and Biotechnology Companies
Datamonitor, March 2002
According to the International Monetary Fund, worldwide economic growth in 2001 was 3.2 per cent, which is lower than that of the pharmaceutical industry highlighting this sector’s defensive characteristics. However, concerns surrounding the sector, such as key patent expirations and the subsequent threat of generic competition, rising R&D costs and marketing needs, continued to loom. Moreover, the very nature of the pharmaceutical industry means that during an economic slowdown the industry is affected less than other sectors, and the impact is likely to occur in the year or two following. This brief presents the financial results for the top 16 pharmaceutical companies and the top ten biotechnology companies in 2001. Datamonitor analyzes total sales, ethical sales and operating profits, comparing growth rates and the factors that have contributed to each company’s performance. Additionally, each company’s expenditure on R&D in 2001, together with growth over 2000 and proportion as a percentage of total and ethical sales is presented in full.
Customers who bought this item also bought
H1 2001 Results: Financial Results of the Top 12 Pharmaceutical Companies
2000 Results: Financial Results of the Top 16 Pharmaceutical Companies
Guide to Pharmaceutical Outsourcing in China: A Handbook for Pharmaceutical and Biotechnology Companies Planning to Outsource to China
Bio/Pharmaceutical R&D Statistical Sourcebook 2007/2008
The Fastest Growing Biotechnology Companies: Growth Strategies, Comparative Analyses and Company Profiles
Pharmaceutical R&D Statistical Sourcebook 2005/2006
Analyzing the Global Pharmaceutical Industry
The Top 10 World's Leading Pharmaceutical Companies
Maximizing Investment of Returns: Analysis of Ethical Sales Growth and Asset Allocation Trends Within the Leading US and EU Pharmaceutical Companies
Indian Pharmaceutical Industry
Pharmaceutical Industry Market Review 2008
The Future of Ethical Food and Drinks: Growth Opportunities In Organic and Sustainable Products And Packaging
|
 |
|
|